Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers November 20, 2017
Pharmacy Choice - Pharmaceutical News - Global Orphan Drugs Market to Grow at a CAGR of 10.20% During 2017-2021 - AbbVie, Celgene, F. Hoffmann La Roche, Novartis - November 20, 2017

Pharmacy News Article

 9/13/17 - Global Orphan Drugs Market to Grow at a CAGR of 10.20% During 2017-2021 - AbbVie, Celgene, F. Hoffmann La Roche, Novartis

Albany, NY (SBWIRE) 09/13/2017 According to Orphan Drug Designation program of the US Food and Drug Administration (FDA), orphan diseases are defined as rare diseases that affects less than 2,00,000 Americans. The global orphan drugs market is expected to benefit from patent extensions like Orphan Drug Exclusivity (ODE), increasing focus of vendors on orphan drug products, and financial incentives provided by government in form of tax credits and waived FDA fees. For instance, the FDA grants a seven-year patent exclusivity to orphan drugs to treat a rare disease. Therefore, any other drug with the same indication cannot be approved by the FDA during these seven-years period.In addition, they also provide tax credits up to 50% of the total R&D cost after the drug receives the orphan drug designation. This credit can be used by the sponsor during the R&D phase of any drug irrespective of the drug designation. The orphan designated drugs are also exempted from paying the FDA fees. Thus, these financial incentives and grants for orphan drug attract many vendors to invest in developing drugs for rare diseases and make huge profits.The global orphan drugs market to grow at a CAGR of 10.20% during the period 2017-2021. The report covers the present scenario and the growth prospects of the global orphan drugs market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.Click to get sample PDF with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=1059719The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEATechnavio's report, Global Orphan Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Browse more details at: http://www.researchmoz.us/global-orphan-drugs-market-2017-2021-report.htmlKey vendors
- AbbVie
- Celgene
- F. Hoffmann La Roche
- NovartisOther prominent vendors
- Amgen
- Actelion
- Alexion Pharmaceuticals
- Bayer
- Biogen
- Bristol-Myers Squibb
- Eli Lilly
- Johnson & Johnson
- Novo Nordisk
- Pfizer
- Sanofi
- Shire
- Teva pharmaceuticalMarket driver
- Large growth opportunities through orphan drug designation.
- For a full, detailed list, view our report Key questions answered in this report
- What will the market size be in 2021 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?About ResearchMoz
ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.Contact Us:
Mr. Nachiket
Albany NY - 12207
United States
Tel: +1-518-621-2074
Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVGFor more information on this press release visit: http://www.sbwire.com/press-releases/global-orphan-drugs-market-to-grow-at-a-cagr-of-1020-during-2017-2021-abbvie-celgene-f-hoffmann-la-roche-novartis-863545.htm

Media Relations Contact

Mr.Nachiket
Manager
Researchmoz Global Pvt. Ltd.
Telephone: 518-621-2074
Email: Click to Email Mr.Nachiket
Web: http://www.researchmoz.us/




Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

LIVE ONLINE CE

Last Chance
Nov 20: Obesity Management: Overview of Pharmacotherapy
Last Chance
Nov 21: Standards of Practice for Filling Controlled Substance Prescriptions in Florida
Nov 22: Medical Marijuana: Examining the Science, Not the Politics
Nov 27: Drug Diversion and the Law: Updates and Considerations
Nov 28: An Integrative Approach to Managing Arthritis
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.



Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415